BOULDER, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOPHIE'S NEIGHBORHOOD, founded in 2020, is a small nonprofit in the Health Care sector that reported $133K in total revenue in fiscal year 2024. Revenue fell 42% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $24K, a strong 18% operating margin.
SOPHIE'S NEIGHBORHOOD IS A NONPROFIT DEDICATED TO FUNDRAISING FOR RESEARCH INTO THE DEVELOPMENT OF AN EFFECTIVE TREATMENT OR CURE FOR AN ULTRA RARE GENETIC DISORDER: MULTICENTRIC CARPOTARSAL OSTEOLYSIS (MCTO)
DURING THE FISCAL YEAR ENDING APRIL 2025, SOPHIE'S NEIGHBORHOOD FUNDED MAJOR RESEARCH INITIATIVES TO ADVANCE UNDERSTANDING AND TREATMENT OF MULTICENTRIC CARPO-TARSAL OSTEOLYSIS (MCTO) AN ULTRA RARE...
DURING THE FISCAL YEAR ENDING APRIL 2025, SOPHIE'S NEIGHBORHOOD FUNDED MAJOR RESEARCH INITIATIVES TO ADVANCE UNDERSTANDING AND TREATMENT OF MULTICENTRIC CARPO-TARSAL OSTEOLYSIS (MCTO) AN ULTRA RARE GENETIC BONE AND KIDNEY DISORDER. 1.ADVANCING MCTO DISEASE MECHANISMS THROUGH INNOVATIVE MOUSE MODELS SOPHIE'S NEIGHBORHOOD SUPPORTED RESEARCH AT HARVARD SCHOOL OF DENTAL MEDICINE INVESTIGATING BONE REMODELING ACTIVITY AND CELLULAR CHANGES MAFB MOUSE MODELS OF MCTO. THIS WORK INCLUDES TRANSCRIPTOMIC ANALYSES OF CELLS AND TISSUES WITHIN THE SKELETAL MICROENVIRONMENT TO UNCOVER MOLECULAR MECHANISMS DRIVING DISEASE PROGRESSION. 2.EXPANDING STEM CELL-BASED AND DEVELOPMENTAL MODELS OF MCTO IN COLLABORATION WITH BOSTON CHILDREN'S HOSPITAL, SOPHIE'S NEIGHBORHOOD CONTINUED TO FUND STUDIES ON MAFB AND DEVELOPMENTAL CHONDROGENESIS. THESE EFFORTS ADVANCE STEM CELL-BASED MODELS OF MCTO AND IDENTIFY KEY TRANSCRIPTIONAL NETWORKS INVOLVED IN BONE AND CARTILAGE DEVELOPMENT. 3.ESTABLISHING CRITICAL RESEARCH INFRASTRUCTURE FOR RARE DISEASE DISCOVERY SOPHIE'S NEIGHBORHOOD SUPPORTED THE CREATION AND ONGOING MAINTENANCE OF MCTO MOUSE LINES WITH SPECIFIC MAFB MUTATIONS AT THE JACKSON LABORATORY. THESE SPECIALIZED MODELS ENABLE RESEARCHERS TO TEST HYPOTHESES RELATED TO MAFB PROTEIN ACCUMULATION AND DISEASE PATHOLOGY, STRENGTHENING THE FOUNDATION FOR FUTURE THERAPEUTIC RESEARCH. 4.INITIATE ANTISENSE OLIGONUCLEOTIDE (ASO) DEVELOPMENT AND SCREENING TO EVALUATE THERAPEUTIC EFFICACY IN CELLULAR AND MOUSE MODELS, WITH THE GOAL OF REVERSING BONE AND KIDNEY PHENOTYPES ASSOCIATED WITH MCTO.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $133,087 | $228,297 | -0.4% |
| Expenses | $109,440 | $267,334 | -0.6% |
| Net Income | $23,647 | $-39,037 | -1.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BLAKE SEDBERRY | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL WEINSTEIN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| HOSEA ROSENBERG | VICE PRESIDE | 5.00 |
Officer
|
$0 | $0 | $0 |
| LAUREN ROSENBERG | PRESIDENT-CE | 25.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $133,087 | $109,440 | $1,020,557 | $23,647 |
| 2024 | $228,297 | $267,334 | $996,910 | $-39,037 |
| 2023 | $236,226 | $82,038 | $1,035,947 | $154,188 |
| 2022 | $325,648 | $81,255 | $881,759 | $244,393 |
| 2021 | $647,128 | $41,102 | $637,366 | $606,026 |
Compare SOPHIE'S NEIGHBORHOOD with other nonprofits in Colorado and across the country.